劉柯俊 研究員－論文

PUBLICATIONS
  1. W. Lee, L.‐T. Wang, M.‐L. Yen, P.‐J. Hsu, Y.‐W. Lee, K.‐J. Liu, K.‐I Lin, Y.‐W. Su, H.‐K. Sytwu; B. L. Yen. Resident vs nonresident multipotent mesenchymal stromal cell interactions with B lymphocytes result in disparate outcomes. Stem Cells Translational Medicine. Pub Date: 2021-01-28, DOI: 10.1002/sctm.20-0289.
  2. L.-T. Wang, S.-K. Chiu, W. Lee, L. K. Siu, K.-J. Liu, M.-L. Yen, B. L. Yen. Protocol for human placental mesenchymal stem cell therapy in a murine model of intra-abdominal infection of hypervirulent Klebsiella. STAR Protocol, 2(1):100337. 2021.
  3. L.-Y. Huang, Y.-P. Hsieh, Y.-Y. Wang, D.-Y. Hwang, S. S. Jiang, W.-T. Huang, W.-F. Chiang, K.-J. Liu, and T.-T. Huang*. Single-Cell Analysis of Different Stages of Oral Cancer Carcinogenesis in a Mouse Model. International Journal of Molecular Sciences, 21,08171. 2020.
  4. C.-H. Lee*, P.-F. Hung, K.-J. Liu, H.-L. Chung, W.-C. Yang, K.-C. Hsu, T.-H. Fong, H.-J. Lo, Y.-P. Chen, J.-R. Yang, C.-Y. Yen*. LDOC1 Suppresses Microbe-induced Production of IL-1β in Human Normal and Cancerous Oral Cells through the PI3K/Akt/GSK-3β Axis. Cancers, 12 (11), 3148; https://doi.org/10.3390/cancers12113148. 2020.
  5. L.-T. Wang, H.-H. Wang, H.-C. Chiang, L.-Y. Huang, S.-K. Chiu, L. K. Siu, K.-J. Liu, M.-L. Yen, B. L. Yen. Human placental MSC-secreted IL-1β enhances neutrophil bactericidal functions during hypervirulent Klebsiella infection. Cell reports, 32(13), 108188. 2020.
  6. B. L. Yen, H.-L. Hwa, P.-J. Hsu, P.-M. Chen, L.-T. Wang, S.-S. Jiang, K.-J. Liu, H.-K. Sytwu and M.-L. Yen. HLA-G Expression in Human Mesenchymal Stem Cells (MSCs) Is Related to Unique Methylation Pattern in the Proximal Promoter as well as Gene Body DNA. International Journal of Molecular Sciences. 21(14), 5075; doi:10.3390/ijms21145075. 2020.
  7. B. L. Yen, M.-L. Yen, L.-T. Wang, K.-J. Liu, H.-K. Sytwu. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID ‐19. Stem Cells Translational Medicine. 9(10):1163. 2020.
  8. S.-J. Leu, Y.-C. Lee, C.-H. Lee, P.-Y. Liao, C.-W. Chiang, C.-M. Yang, C.-H. Su, T.-Y. Ou, K.-J. Liu, H.-J. Lo, B.-Y. Tsai, Y.-Y. Yang. Generation and Characterization of Single Chain Variable Fragment against Alpha-Enolase of Candida albicans. International Journal of Molecular Sciences. 21(8):2903. doi: 10.3390/ijms21082903. 2020.
  9. T.-F. Hsiao, C.-L. Wang, Y.-C. Wu, H.-P. Feng, Y.-C. Chiu, H.-Y. Lin, K.-J. Liu, Gee-Chen Chang, K.-Y. Chien, J.-S. Yu. Integrative omics analysis reveals soluble cadherin-3 as a survival predictor and an early monitoring marker of EGFR tyrosine kinase inhibitor therapy in lung cancer. Clinical Cancer Research, 26(13):3220-3229. 2020.
  10. K.-C. Hsiao, P.-Y. Chu, G.-C. Chang*, K.-J. Liu*. Elevated expression of lumican in lung cancer cells promotes bone metastasis through an autocrine regulatory mechanism. Cancers, 12, 233; doi:10.3390/cancers12010233. 2020. (*corresponding author)
  11. C.-Y. Huang, L.-H. Hsu, C.-Y. Chen, G.-C. Chang, H.-W. Chang, Y.-M. Hung, K.-J. Liu*, S.-H. Kao*. Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy. Cancers, 12, 181; doi:10.3390/cancers12010181. 2020. (*corresponding author)
  12. Y.-L. Chen*, K.-J. Liu*, C.-W. Jang, C.-C. Hsu, Y.-C. Yen, Y.-L. Liu, T.-H. Chuang, S.-H. Wang, Y.-K. Fu, C.-C. Kuo, Y.-W. Chen. ERK activation modulates cancer stemness and motility of a novel mouse oral squamous cell carcinoma cell line. Cancers. 12, 61;doi:10.3390/cancers12010061. 2020. (*first author)
  13. C.-P. Tien, C.-H. Chen, W.-Y. Lin, C.-S. Liu, K.-J. Liu, M. Hsiao, Y.-C. Chang. Ambient Particulate Matter Attenuates Sirtuin1 and Augments SREBP1-PIR Axis to Induce Human Pulmonary Fibroblast Inflammation: Molecular Mechanism of Microenvironment Associated with COPD. Aging. 11(13):4654-4671. 2019.
  14. L.-T. Wang, S.-S. Jiang, C.-H. Ting, P.-J. Hsu, C.-C. Chang, H.-K. Sytwu1, K.-J. Liu, B. L. Yen. Differentiation of MSCs from human iPSCs results in downregulation of c-Myc & DNA replication pathways with immunomodulation towards CD4 & CD8 cells. Stem Cells. 36(6):903-914. 2018.
  15. S.-J. Leu, Y.-Y. Yang, H.-C. Liu, C.-Y. Cheng, Y.-C. Wu, M.-C. Huang, Y.-L. Lee, C.-C. Chen, W. W. Shen, K.-J. Liu*. Valproic acid and lithium meditate anti-inflammatory effects by differentially modulating dendritic cell differentiation and function. Journal of Cellular Physiology. 232:1176-1186. 2017. (*corresponding author)
  16. K.-J. Liu*, T.-Y. Chao, J.-Y. Chang, A.-L. Cheng, H.-J. Ch’ang, W.-Y. Kao, Y.-C. Wu, W.-L. Yu, T.-R. Chung, and J. Whang-Peng*. A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment. Journal of Biomedical Science. 23:64-74. 2016. (*corresponding author)
  17. L.-T. Wang, C.-H. Ting, M.-L. Yen, K.-J. Liu, H.-K. Sytwu, Kenneth K. Wu, and B. L Yen. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. Journal of Biomedical Science. 23:76-88. 2016.
  18. K.-C. Hsiao, N.-Y. Shih, P.-Y. Chu, Y.-M. Hung, J.-Y. Liao, S.-W. Chou, Y.-Y. Yang, G.-C. Chang*, K.-J. Liu*. Anti--enolase is a prognostic marker in postoperative lung cancer patients. Oncotarget. 6(33):35073-35086. 2015. (*corresponding author)
  19. C.-H. Lee, S.-H. Syu, K.-J. Liu, P.-Y. Chu, W.-C. Yang, P. Lin, W.-Y. Shieh. Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer. Oncotarget. 6(36):38866-38880. 2015.
  20. W.-B. Wang, M.-L. Yen, K.-J. Liu*, P.-J. Hsu, M.-H. Lin, P.-M. Chen, P.-R. Sudhir, C.-H. Chen, C.-H. Chen, H.-K. Sytwu, B. L. Yen*. Interleukin-25 mediates transcriptional control of PD-L1 through STAT3 in multipotent human mesenchymal stromal cells (hMSCs) to suppress Th17 responses. Stem Cell Reports. 5(3):392-404. 2015. (*corresponding author)
  21. P.-J. Hsu, K.-J. Liu, H.-K. Sytwu, B. L. Yen. Assessment of the immunomodulatory properties of human mesenchymal stem cells (MSCs). Journal of Visualized Experiments. 106:e53265. 2015.
  22. C.-H. Yang, H.-C. Chou, Y.-N. Fu, C.-L. Yeh, H.-W. Cheng, I.-C. Chang, K.-J. Liu, G.-C. Chang, T.-F. Tsai, S.-F. Tsai, H.-P. Liu, Y.-C. Wu, Y.-T. Chen, S.-F. Huang, Y.-R Chen, EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82. BBA-Molecular Basis of Disease. 1852(7):1540-1549. 2015.
  23. L.-H. Hsu, K.-J. Liu, M.-F. Tsai, C.-R. Wu, A.-C. Feng, N.-M. Chu, S.-H. Kao. Estrogen adversely affects the prognosis of patients with lung adenocarcinoma. Cancer Science. 106(1):51-59. 2015.
  24. C.-H. Lee*, S.-H. Syu, T.-S. Wong, J. Y.-W Chan, Y.-C. Tang, Z.-P. Yang, J. S.-M. Chang, W.-C. Yang, C.-T. Chen, S.-C. Lu, P.-H. Tang, T.-C. Yang, P.-Y. Chu, J.-R. Hsiao, and K.-J. Liu*. IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer. Journal of Cellular Physiology. 230:875-884. 2015. (*corresponding author)
  25. P.-M. Chen, K.-J. Liu, P.-J. Hsu, C.-F. Wei, C.-H. Bai, L.-J. Ho, H.-K. Sytwu, and B. L. Yen. Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2. Journal of Leukocyte Biology. 2014. jlb.3A0513-242R; doi:10.1189/jlb.3A0513-242R
  26. C.-C. Chen, L.-L. Chen, Y.-T. Hsu, K.-J. Liu, C.-S. Fan, and T.-S. Huang. The Endothelin-Integrin Axis is Involved in Macrophage-Induced Breast Cancer Cell Chemotactic Interactions with Endothelial Cells. Journal of Biological Chemistry. 289(14):10029-10044. 2014.
  27. T.-E. Hua, T.-L. Yang, W.-C. Yang, K.-J. Liu* and S.-C. Tang*. 3-D neurohistology of transparent tongue in health and injury with optical clearing. Frontiers in Neuroanatomy. 7:36. doi: 11.3389/fnana.2013.00036. 2013. (*corresponding author)
  28. K.-C. Hsiao, N.-Y. Shih, H.-L. Fang, T.-S. Huang, C.-C. Kuo, P.-Y. Chu, Y.-M. Hung, S.-W. Chou, Y.-Y Yang, G.-C. Chang*, K.-J. Liu*. Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target. PLOS ONE. 8(7): e69354. doi:10.1371/journal.pone.0069354. 2013. (*corresponding author)
  29. C.-C. Chen, C.-B. Chu, K.-J. Liu, C.-Y. Huang, J.-Y. Chang, W.-Y. Pan, H.-H. Chen, Y.-H. Cheng, K.-D. Lee, M.-F. Chen, C.-C. Kuo, and L.-T. Chen. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification. Biochemical Pharmacology. 86(7):872-887. 2013.
  30. B. L. Yen, M.-L. Yen, P.-J. Hsu. K.-J. Liu. C.-J. Wang. C.-H. Bai, H.-K. Sytwu. Multipotent human mesenchymal stromal cells mediate the expansion of myeloid-derived suppressor cells through the HGF/c-met axis and STAT3. Stem Cell Reports. 1(2):139-151. 2013.
  31. K.-Y. Chang, S.-Y. Tsai, S.-H. Chen, H.-H. Tsou, C.-J. Yen, K.-J. Liu, H.-L. Fang, H.-C. Wu, B.-F. Chuang, S.-W. Chou, C. K. Tang, S.-Y. Liu, P.-J. Lu, C.-Y. Yen and J.-Y. Chang. Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance. Journal of Biomedical Science. 20:43-52. 2013.
  32. C.-L. Chu, Y.-L. Yu, Y.-C. Kung, P.-Y. Liao, K.-J. Liu, Y.-T. Tseng, Y.-C. Lin, S. S.-Y. Hsieh, P. C.-S. Chong, C.-Y. Yang. The immunomodulatory activity of meningococcal lipoprotein Ag473 depends on the conformation made up of the lipid and protein moieties. PLOS ONE. 7(7): e40873. doi:10.1371/journal.pone.0040873. 2012.
  33. K.-L. Chen, W.-S. Chang, C.-H. Cheung, C.-C. Lin, C.-C. Huang, Y.-N. Yang, C.-P. Kuo, C.-C. Kuo, Y.-H. Chang, K.-J. Liu, C.-M. Wu, and J.-Y. Chang. Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway. Cancer Letters. 317:89-98, 2012.
  34. K.-J. Liu, C.-J. Wang, C.-J. Chang, H.-I. Hu, Y.-C. Wu, P.-J. Hsu, H.-K. Sytwu, and B. L. Yen. Surface expression of HLA-G is involved in mediating immunomodulatory effects of placenta-derived multipotent cells (PDMCs) towards natural killer lymphocytes. Cell Transplantation. 20:1721-1730, 2011.
  35. K.-J. Liu*, Y.-L. Lee*, Y.-Y. Yang, N.-Y. Shih, C.-C. Ho, Y.-C. Wu, T.-S. Huang, M.-C. Huang, H.-C. Liu, W. W. Shen, and S.-J. Leu. Modulation of the Development of Human Monocyte-Derived Dendritic Cells by Lithium Chloride. Journal of Cellular Physiology. 226:424-433, 2011. (*first author)
  36. C.-C. Lee, K.-J. Liu, S.-F. Yo, C.-C. Chang, and T.-S. Huang. Sesamin inhibits the angiogenic activity of macrophage-affected breast cancer cells via suppression of Cytokine-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression. Inflammation. 34(3):209-211, 2011.
  37. P.-M. Chen, M.-L. Yen, K.-J. Liu, H.-K. Sytwu and B. L. Yen. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. Journal of Biomedical Science. 18(1):49-59, 2011.
  38. C.-C. Lin, Y.-L. Yu, C.-C. Shih, K.-J. Liu, K.-L. Ou, ·L.-Z. Hong, J. D. C. Chen, C.-L. Chu. A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunology and Immunotherapy, 60(7):1019-1027, 2011.
  39. H.-H. Chen, W. Chiang, J.-Y. Chang, Y.-L. Chien, C.-K. Lee, K.-J. Liu, Y.-T. Cheng, T.-F. Chen, Y.-H. Kuo, C.-C. Kuo. Antimutagenic Constituents of Adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) with Potential Cancer Chemopreventive Activity. Journal of Agricultural and Food Chemistry, 59:6444-6452, 2011.
  40. K.-J. Liu, S.-J. Leu, C.-H. Su, B.-L. Chiang, Y.-L. Chen, and Y.-L. Lee. Administration of polysaccharides from Antrodia camphorata modulates dendritic cell function and alleviates allergen-induced Th2 responses in a mouse model of asthma. Immunology, 129(3):351-362, 2010.
  41. J. Lung, K.-J. Liu, J.-Y. Chang, S.-J. Leu, and N.-Y Shih. MBP-1 is efficiently encoded by an alternative transcript of the ENO1 gene but post-translationally regulated by proteasome-dependent protein turnover. FEBS Journal. 277(20):4308-4321. 2010.
  42. N.-Y. Shih, H.-L. Lai, G.-C. Chang, H.-C. Lin, Y.-C. Wu, J. M. Liu, K.-J. Liu and S.-W. Tseng. Anti--enolase autoantibodies are down-regulated in advanced cancer patients. Japanese Journal of Clinical Oncology. 40(7):663-669. 2010.
  43. S.-J. Leu, Y.-C. Lee, N.-Y. Shih, I-J. Huang, K.-J. Liu, H.-F. Lu, S.-Y. Huang and Y.-Y. Yang. Generation and characterization of anti--enolase single-chain antibodies in chicken. Veterinary Immunology and Immunopathology. 137:251-260. 2010.
  44. J.-C. Chen, B.-J. Uang, P.-C. Lyu, J.-Y. Chang, K.-J. Liu, C.-C. Kuo, H.-P. Hsieh, H.-C. Wang, C.-S. Cheng, M.D.-T. Chang, W.-S.W. Chang, C.-C. Lin, Design and synthesis of α-ketoamides as cathepsin S inhibitors with potential applications against tumor invasion and angiogenesis. Journal of Medicinal Chemistry, 53(11):4545-9, 2010.
  45. N.-Y. Shih, H.-Y. Yang, H.-T. Cheng, Y.-M. Hung, Y.-C. Yao, Y.-H. Zhu, Y.-C. Wu and K.-J. Liu*. Conditioning vaccination site with irradiated MIP-3 alpha-transfected tumor cells enhances efficacy of dendritic cell-based cancer vaccine against tumor challenge. Journal of Immunotherapy, 32(4):363, 2009. (*corresponding author)
  46. B. L. Yen, C.-J. Chang, K.-J. Liu, Y.-C. Chen, H.-I Hu and M.-L. Yen. Human embryonic stem cell-derived mesenchymal progenitors (EMPs) possess strong immunosuppressive effects towards natural killer cells as well as T lymphocytes. Stem Cells, 27(2):451, 2009.
  47. Y.-M. Shiao, Y.-H. Chang, Y.-M. Liu, J.-C. Li, J.-S. Su, K.-J. Liu, Y.-F. Liu, M.-W. Lin and S.-F. Tsai. Dysregulation of GIMAP genes in non-small cell lung cancer. Lung Cancer, 62(3):287, 2008.
  48. K.-J. Liu and N.-Y. Shih. The role of enolase in tissue invasion and metastasis of pathogens and tumor cells. Journal of Cancer Molecules, 3(2):45, 2007.
  49. K.-J. Liu. Dendritic cell, toll-like receptor, and the immune system. Journal of Cancer Molecules, 2(6):213, 2006.
  50. G.-C. Chang, K.-J. Liu, C.-L. Hsieh, T.-S. Hu, S. Charoenfuprasert, H.-K. Liu, K.-T. Luh, L.-H. Hsu, C.-W. Wu, C.-C. Ting, C.-Y. Chen, K.-C. Chen, T.-Y. Yang, T.-Y. Chou, W.-H. Wang, J. Whang-Peng and N.-Y. Shih. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clinical Cancer Research, 12(19):5747, 2006.
  51. K.-J. Liu and C.-L. Chu. Current progress in dendritic cell research. Journal of Cancer Molecules, 2(6): 217, 2006.
  52. C.-C. Lee, K.-J. Liu, L.-L. Chen, Y.-C. Wu and T.-S. Huang. Tumor necrosis factor-, interleukin-8 and interleukin-6 are involved in vascular endothelial cell capillary tube and network formation induced by tumor-associated macrophages. Journal of Cancer Molecules, 2(4): 155, 2006.
  53. C.-C. Lee, K.-J. Liu and T.-S. Huang. Tumor-associated macrophage: its role in tumor angiogenesis. Journal of Cancer Molecules, 2(4): 135, 2006.
  54. G.-C. Chang, H.-C. Lan, S.-H. Juang, Y.-C. Wu, H.-C. Lee, Y.-M. Hung, J. Whang-Peng and K.-J. Liu*. A Pilot Clinical Trial of Vaccination with Dendritic Cells Pulsed with Autologous Tumor Cells Derived from Malignant Pleural Effusion in Patients with Late-stage Lung Cancer. Cancer, 103(4):763, 2005. (*corresponding author)
  55. C.-C. Chen, J.-Y. Chang, K.-J. Liu, C. Chan, C.-H. Ho, S.-C. Lee and L.-T. Chen. Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis. Annals of Oncology, 16(6):988, 2005.
  56. K.-J. Liu, C.-C. Wang, L.-T. Chen, A.-L. Cheng, D.-T. Lin, Y.-C. Wu, W.-L. Yu, Y.-M. Hung, H.-Y. Yang, S.-H. Juang and J. Whang-Peng. Generation of CEA-specific T cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides. Clinical Cancer Research, 10(8):2645, 2004.
  57. K.-J. Liu*, L.-F. Lu, H.-T. Cheng, Y.-M. Hung, S.-R. Shiou, J. Whang-Peng and S.-H. Juang. Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells. Cancer Gene Therapy, 11:135, 2004. (*corresponding author)
  58. K.-J. Liu, C.-T. Chen, W. S. Hu, Y.-M. Hung, C.-Y. Hsu, B.-F. Chuang and S.-H. Juang. Expression of cytoplasmic-domain substituted epeidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme. International Journal of Oncology, 24(3):581, 2004.
  59. S.-H. Juang, S.-J. Wei, C.-Y. Hsu, Y.-M. Hung, K.-J. Liu, D.-M. Yang, W.-S. Chen and W. K. Yang. Interferon- induces Caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines. Journal of Interferon and Cytokine Research, 24(4):231, 2004.
  60. K.-J. Liu, M.S. Schwen, P.W. Tucker and B.S. Kim. Hybrid membrane IgM with the transmembrane region of I-A facilitates enhanced presentation of distinct epitopes to T cells. Journal of Immunology, 160:4161, 1998.
  61. K.-J. Liu, G.S. Chatta, D.R. Twardzik, T.S. Vedvick, L.D. True, A.G. Spies and M.A. Cheever. Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy. Journal of Immunology, 159:472, 1997.
  62. K.-J. Liu, V.S. Parikh, P.W. Tucker and B.S. Kim. Surface immunoglobulins mediate efficient transport of antigen to lysosomal compartments resulting in enhanced specific antigen presentation by B cells. European Journal of Immunology, 24:2755, 1994.
  63. K.-J. Liu, V.S. Parikh, P.W. Tucker and B.S. Kim. Role of the B cell antigen receptor in antigen processing and presentation: Involvement of transmembrane region in intracellular trafficking of receptor/ligand complexes. Journal of Immunology, 151:6143, 1993.
  64. V.S. Parikh, G. Bishop, K.-J. Liu, B.T. Do, M.R. Ghosh, B.S. Kim and P.W. Tucker. Differential structure-function requirements of the transmembranal domain of the B cell antigen receptor. Journal of Experimental Medicine, 176:1025, 1992.
  65. K.-J. Liu, Y-F. Wang, S-F. Hwang and T.C. Tung. Effect of orally administered Chinese medicinal prescriptions on murine macrophage phagocytosis. Journal of Chinese Oncology Society, 4(4):1, 1989.
  66. S.-F. Huang, K.-J. Liu, Y.-H. Kuan, K.-S. Tung, C.-H. Su and T.-C. Tung. The inhibitory effect of artificial pulmonary metastasis of murine S-180 sarcoma cells by orally administered Ganoderma lucidum culture broth. Journal of Chinese Oncology Society, 5(1):10, 1989.
  67. K.-J. Liu, S.-F. Hwang, C.-H. Su and T.-C. Tung. Absorption of orally administered polysaccharide from Ganoderma lucidum: study on oral administration of C14-labelled broth from mycelial culture of Ganoderma lucidum in ICR mice. Journal of Chinese Oncology Society, 5(2):22, 1989.
  68. K.-J. Liu, S.-H. Hwang, W.-H. Lee and T.-C. Tung. Effect of orally administered Chinese medicinal prescriptions on murine macrophage phagocytosis: study on polysaccharides containing extract of Glycyrrizae radix and Paeoniae radix. Journal of Chinese Oncology Society, 5(3):24, 1989.

Book:

  1. Liu KJ, Yen ML, Wang LT, Yen BL. The modulatory effects of mesenchymal stromal cells (MSCs) on the innate immune system. In: The Biology & Therapeutic Applications of Mesenchymal Cells, pps.481-489, editor Atkinson K, Wiley & Sons, Inc., Hoboken, NJ, USA, 2016.
  2. Yen BL, Liu KJ, Yen ML, Sytwu HK. The modulatory effects of MSCs on the adaptive immune system. In: The Biology & Therapeutic Applications of Mesenchymal Cells, pps. 490-495, editor Atkinson K, Wiley & Sons, Inc., Hoboken, NJ, USA, 2016.
  3. Yen BL, Yen ML, Liu KJ, Chiu RC. Recent Advances in Stem Cell Immune Tolerance, In: ed. Immune Tolerance Research Developments. Chapter 7, pp. 151-166, editor Emile B. Pontell, Nova Science Publishers, Hauppauge, NY, USA, 2008.
Share Button

Comments are closed.